Pediatric Updates: Pharmacology: Psychopharmacology: 3rd Edition
PNCB's third edition of all new in-depth psychopharmacology CE includes 12 journal articles for your references. Whether you treat and prescribe—or manage other care for youth taking these medications under another provider's care—this is a must-take module given the prevalence of behavioral and mental health conditions among children and teens. Topics covered:
- Treatment guidelines for ADHD, anxiety, and care of adolescents with depression in the primary care setting (recently updated ADHD, anxiety, & depression management guidelines)
- Recommendations and emerging evidence for treatment of children and adolescents with ADHD, depression, and autism spectrum disorder and comorbid mental health diagnoses including:
- ADHD + autism, ADHD + oppositional defiant disorder, ADHD + bipolar disorder, ADHD + obsessive-compulsive disorder, ADHD + Tourette syndrome
- Depression + comorbid substance use disorders
- ASD + behavioral disturbances, ASD + sleep disturbances
- Management of depression in children and adolescents with medical illness
- Recommendations and available evidence for pharmacologic treatment for children and adolescents with bipolar disorder, obsessive-compulsive disorder, agitation, and delirium
- Adverse effects, FDA “black box warnings,” and medication interactions for psychopharmacologic agents used for treatment of children and adolescents with mental health diagnoses
- Monitoring for and treatment of adverse effects associated with psychopharmacologic agents
